Design Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-3.6M | $77.0K |
| FY2020 | — | $-11.3M | $2.4M |
| FY2021 | — | $382.1M | $298.6M |
| FY2022 | — | $327.3M | $26.5M |
| FY2023 | — | $277.7M | $21.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-3.6M | $77.0K |
| FY2020 | — | $-11.3M | $2.4M |
| FY2021 | — | $382.1M | $298.6M |
| FY2022 | — | $327.3M | $26.5M |
| FY2023 | — | $277.7M | $21.2M |